(Total Views: 803)
Posted On: 07/11/2022 12:39:42 PM
Post# of 148899
https://youtu.be/uxkc6Ql1C-U
This video above on Tumor micro environment and how Leronlimab works on Cancer makes me wonder if Leronlimab was able to isolate the CCR5 receptor with one dose using cutting edge Adeno-associated Virus (AAV) vectors for the HIV Functional Cure… Would it also stay and protect against Cancer also forever? Essentially a Cancer Vaccine for the HIV population as a great side effect of functional curing HIV and or Cancer too… or essentially two birds with one stone type of possible cure? How many other indications would be cured by permanently blocking the CCR5 receptor? This funded study I assume… is to see what other effects permanently blocking the CCR5 receptor will have… will it be benefit or not be any benefit by permanently blocking the CCR5?
Maybe Ohm20 can weigh in on this conversation?
From Stocktwits:
nom_de_gar
7:54 AM
$CYDY "Adeno-associated virus (AAV) vectors are the leading platform for gene delivery for the treatment of a variety of human diseases. Recent advances in developing clinically desirable AAV capsids, optimizing genome designs and harnessing revolutionary biotechnologies have contributed substantially to the growth of the gene therapy field. Preclinical and clinical successes in AAV-mediated gene replacement, gene silencing and gene editing have helped AAV gain popularity as the ideal therapeutic vector, with two AAV-based therapeutics gaining regulatory approval in Europe or the United States. Continued study of AAV biology and increased understanding of the associated therapeutic challenges and limitations will build the foundation for future clinical success."
-- Nature Reviews Drug Discovery (2019)
(4)
(0)
Scroll down for more posts ▼